Last reviewed · How we verify

PTH/Calcium — Competitive Intelligence Brief

PTH/Calcium (PTH/Calcium) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hormone replacement / Mineral supplement combination. Area: Endocrinology.

phase 3 Hormone replacement / Mineral supplement combination PTH receptor (PTH1R) Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

PTH/Calcium (PTH/Calcium) — Shire. This combination therapy works by supplementing parathyroid hormone (PTH) to regulate calcium homeostasis and bone metabolism.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
PTH/Calcium TARGET PTH/Calcium Shire phase 3 Hormone replacement / Mineral supplement combination PTH receptor (PTH1R)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hormone replacement / Mineral supplement combination class)

  1. Shire · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). PTH/Calcium — Competitive Intelligence Brief. https://druglandscape.com/ci/pth-calcium. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: